“5 Questions With…” is a weekly BioBuzz series where we reach out to interesting people in the BioHealth Capital Region and Greater Philadelphia to share a little about themselves, their work, and maybe something completely unrelated.
Well, we decided to shake things up. Instead of publishing an interview-style “5 Questions With…” featuring one of our community members, we asked our community “5 Questions About” our very own Andy Eckert.
Studying procrastination used to be a terrific way to avoid doing things I was supposed to be doing. It hasn’t been as much fun for me since one of the things I supposed to be doing was writing this column on how to manage procrastinators. Rats!
One thing I learned before I was distracted from my studies is that about 20 percent of adults identify themselves as chronic procrastinators. That is, they are habitually unable to perform tasks on time, even when there are serious consequences involved. Moreover, reports DePaul University psychology professor Joseph Ferrari, author of Still Procrastinating? The No-Regrets Guide to Getting It Done, the incidence of procrastination is pretty consistent across age cohorts, gender, and nationalities. As yet, procrastination researchers have not identified any “blue zones” — Shangri-las in which people not only live longer, but also never miss a deadline.
WASHINGTON – Today, U.S. Senators Chris Coons (D-Del.) and Tim Scott (R-S.C.) and U.S. Representatives Jason Crow (D-Colo.) and Troy Balderson (R-Ohio) introduced the Next Generation Entrepreneurship Corps Act to encourage new business and job creation in underserved communities through a competitive fellowship for entrepreneurs. With a six-year investment of $330 million, the bill will identify talented entrepreneurs through a national competition and directly support the creation of 320 new businesses each year.
Johns Hopkins Technology Ventures (JHTV) has had a significant impact on the Maryland life sciences ecosystem since its founding in 2014, assisting with hundreds of licensed therapeutics in development and backing nearly 200 startups that have collectively nearly $3 billion in venture capital funding, 30% of which has remained in the state.
The Earth has finally attained popular recognition for its fifth ocean, with a decision by the National Geographic Society to add the Southern Ocean around Antarctica to the four it recognizes already: the Atlantic, Pacific, Indian and Arctic oceans.
Although the designation of the frigid waters around the icy southern continent as a separate ocean has kicked around for almost 100 years and is widely used by scientists, until now it has not had popular backing.
A D.C. hospital has once again scored well in U.S. News & World Report’s annual ranking of the nation’s best children’s hospitals.
And the one ranked second-best overall is just a few hours away.
Children’s Hospital of Philadelphia ranked second in the annual U.S. News Honor Roll, with D.C.’s Children’s National Hospital not far behind at seventh overall.
Dr. Kurt Newman, the president and CEO of Children’s National, noted that it marks the fifth year in a row that Children’s National has been ranked among the top 10 nationwide.
Join us Sunday, June 27 at 3:45 PM GMT for our next session of Saving Lives with Autotransfusion: Lessons from the Field—a Sisu Global webinar series where clinicians speak about their experience using Hemafuse in surgery and other global health issues.
Today, the Biotechnology Innovation Organization (BIO) presented Maryland Governor Larry Hogan with its 2021 Governor of the Year Award. Governor Hogan received the award virtually at BIO Digital 2021.
With the annual award, BIO honors governors for their leadership in public service, commitment to public health, and dedication to strengthening the biotechnology sector in their state. For over a decade, the long-standing award has recognized governors from across the country and both sides of the aisle.
Image: https://en.wikipedia.org/wiki/Larry_Hogan
FREDERICK, Md., June 16, 2021 /PRNewswire/ — Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the closing of a $16.6 million Series A financing. The round was led by Hatteras Venture Partners with participation from Genesys Capital, Point Field Partners and Alexandria Venture Investments as well as support from previous Veralox investors including Sanofi Ventures, JDRF T1D Fund, Maryland Momentum Fund, VTC Innovation Fund and TEDCO. The Company also announced that Ben Scruggs, PhD, principal at Hatteras Venture Partners, and Jamie Stiff, MBA, managing director at Genesys Capital, will join the Veralox Therapeutics board of directors.
This is the annual report published by the National Academy of Inventors (NAI) and the Intellectual Property Owners Association (IPO) on top university patent holders. The Top 100 Worldwide Universities Granted U.S. Utility Patents in 2020 were compiled using data obtained from the U.S. Patent and Trademark Office (USPTO). The Top 100 highlights the vital role patents play in translating university research and innovation. Published annually by the NAI and IPO since 2013, the report ranks the top 100 universities named as the first assignee on utility patents granted by the USPTO during the 2020 calendar year.
